Clinical Trials Browser

Phase 2 × Kidney Neoplasms × Irinotecan × Clear all

Bone Neoplasms, Breast Neoplasms, Glioma, Kidney Neoplasms, Lung Neoplasms, Lymphoma, Non-Hodgkin, Neoplasm Metastasis, Neoplasms, Hereditary Sensory and Autonomic Neuropathies, Pancreatic Neoplasms, Sarcoma, Colorectal Neoplasms, Leukemia-Lymphoma, Adult T-Cell

NCT00089102 2018-07-16

Gemcitabine and Irinotecan in Treating Patients With Locally Advanced Unresectable or Metastatic Kidney Cancer

Phase 2 Terminated

9 enrolled 8 charts

Genitourinary

Carcinoma, Renal Cell, Kidney Neoplasms

NCT00401128 2017-04-20

Gemcitabine and Irinotecan in Treating Patients With Metastatic Kidney Cancer

Phase 2 Completed

9 enrolled

Genitourinary

Carcinoma, Renal Cell, Kidney Neoplasms

Clinical Trials

9-ING-41 in Patients with Advanced Cancers

Gemcitabine and Irinotecan in Treating Patients With Locally Advanced Unresectable or Metastatic Kidney Cancer

Gemcitabine and Irinotecan in Treating Patients With Metastatic Kidney Cancer